Compare ADMA Biologics Inc (ADMA) vs FirstEnergy Corp. (FE) Price & Performance

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

FirstEnergy (FE) trades at $48.39, down 0.25% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $52.25. The company reported revenue of $15.09 billion in 2025, with net income of $1.02 billion, and recent earnings have mostly beaten expectations. Positive news highlights growth from data center demand and a $36 billion investment plan for grid upgrades.

The outlook is supported by earnings visibility and strategic investments, but risks include regulatory uncertainty and high debt levels. With no sell ratings from analysts and a dividend payout scheduled, FE presents a steady utility investment with moderate upside potential balanced by sector-specific headwinds.